)
)
)
Tessera Therapeutics
Tessera Therapeutics is pioneering Gene Writing™—a new genome engineering technology that writes therapeutic messages into the genome to treat diseases at their source. Our mission is to cure disease by writing in the code of life.
Year Founded
2018
Lead Product in Development
In vivo gene editing of alpha-1 antitrypsin deficiency (AATD).
Development Phase of Lead Product
Phase I
CEO/Top Company Official
Michael Severino
When you expect your next catalyst update?
2026
){kind=logo}
)
)
){kind=logo}
)
){kind=logo}
){kind=logo}
){kind=logo}
